Probiotics in Prevention and Treatment of COVID-19: Review of Latest Evidence Dr. Mukesh Kumar Gupta9 Jun 2021 12:45 PM ISTThe novel coronavirus pandemic of 2019 (COVID-19) continues to evolve and threaten the world beyond the first wave with emerging infections caused...
BP control in Severe Hypertension: Combination of Amlodipine and Telmisartan more efficacious than monotherapy Hina Zahid5 Jun 2021 11:15 AM ISTIndia at the brink of a hypertension epidemic!Globally >1 billion adults suffer from hypertension and this figure is expected to rise to 1.5...
Transcatheter therapies, future of tricuspid regurgitation management: Glances from EuroPCR 2021 dr. Abhimanyu Uppal25 May 2021 10:30 AM ISTTranscatheter therapies for tricuspid valve disease are ready to take the front seat in management of tricuspid valve disease, as evidenced by three...
Heart Failure 2021 Update: What physicians need to know dr. Abhimanyu Uppal14 May 2021 12:45 PM ISTHeart failure is a progressive chronic syndrome characterized by decrease in functional status and quality of life, and an increased morbidity and...
Combatting the second COVID 19 wave in India: Defining the role of Favipiravir dr. Abhimanyu Uppal12 May 2021 12:45 PM ISTAs India battles the second COVID-19 wave across all states, the healthcare system is overburdened with daily cases skyrocketing to more than 1.5 lac...
Reports of blood clots post COVID-19 vaccine: What should I tell my patients? dr. Abhimanyu Uppal1 May 2021 8:15 AM ISTThe American Heart Association/American Stroke Association (AHA/ASA) has released guidance to help physicians respond to, and understand, the reports...
Cardiovascular Risk of NSAIDS- Clinical implications Hina Zahid28 April 2021 11:39 AM ISTPain is a distressing feeling and is the commonest symptom in clinical practice. It affects the quality of life. Sleep can be disturbed. The...
Amlodipine and Atenolol - The two most time-tested anti-hypertensives of 21st century dr. Abhimanyu Uppal27 April 2021 12:42 PM ISTCardiovascular disease is the leading cause of death worldwide, and hypertension is a modifiable risk factor for cardiovascular disease. Risk...
The versatile drug Trimetazidine: Applications in angina and beyond Dr Tiny Nair26 April 2021 12:45 PM ISTTrimetazidine (TMZ), an anti-anginal agent with a unique pleiotropic profile of actions on the cardiac cells making it an effective anti-anginal...
Mavacamten in HOCM, is it good enough to replace older therapies? dr. Abhimanyu Uppal27 March 2021 11:15 AM ISTThe application of contemporary treatment strategies to hypertrophic cardiomyopathy (HCM) has transformed its prognosis from one of grim progression...
Propranolol and its current status in cardiovascular disorders dr. Abhimanyu Uppal25 March 2021 6:30 AM ISTPropranolol, initially introduced as an antianginal agent, has now established its benefits around a wide spectrum of medical disorders ranging from...
Cardiovascular benefits of ketone diet: just a gimmick or real science? dr. Abhimanyu Uppal16 March 2021 11:45 AM ISTMetabolic perturbations underlie a variety of cardiovascular disease states; yet, metabolic interventions to prevent or treat these disorders are...
